|
|
| | Ralinepag Basic information |
| Product Name: | Ralinepag | | Synonyms: | Ralinepag;Sapanisertib;2-(((1R,4R)-4-((((4-CHLOROPHENYL)(PHENYL)CARBAMOYL)OXY)METHYL)CYCLOHEXYL)METHOXY)ACETIC ACID;APD 811;APD811;APD-811;APD811;APD-811;APD 811;RALINEPAG;Acetic acid, 2-[[trans-4-[[[[(4-chlorophenyl)phenylamino]carbonyl]oxy]methyl]cyclohexyl]methoxy]- | | CAS: | 1187856-49-0 | | MF: | C23H26ClNO5 | | MW: | 431.91 | | EINECS: | | | Product Categories: | | | Mol File: | 1187856-49-0.mol |  |
| | Ralinepag Chemical Properties |
| storage temp. | Store at -20°C | | solubility | DMF: 15mg/mL; DMF:PBS (pH 7.2) (1:8): 0.11mg/mL; DMSO: 10mg/mL; Ethanol: 10mg/mL | | form | A solid | | color | White to off-white |
| | Ralinepag Usage And Synthesis |
| Uses | Ralinepag, is a potent non-prostanoid prostacyclin receptor agonist, with EC50s of 8.5 nM, 530 nM and 850 nM for human and rat IP receptor and human DP1 receptor, respectively. |
| | Ralinepag Preparation Products And Raw materials |
|